Pharmacodynamic model of rocuronium in patients with muscle relaxation: comparison of electromyography-based and acceleromyography-based neuromuscular monitoring
Not Applicable
- Conditions
- Patients scheduled for surgery under general anesthesia that requires neuromuscular blockade only for intubation
- Registration Number
- JPRN-UMIN000044298
- Lead Sponsor
- Showa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with severe hepatic, renal, or cardiovascular disease, neuromuscular disease, a history of rocuronium allergy, body mass index greater than 35 kg/m2
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacodynamic model of rocuronium in patients with deep muscular blockade using electromyography-based and acceleromyography-based neuromuscular monitoring
- Secondary Outcome Measures
Name Time Method (1) Difference in rocuronium pharmacodynamic models between electromyography-based and acceleromyography-based neuromuscular monitoring (2) Pharmacodynamic parameters of rocuronium (3) Relationship between effect-site concentration and neuromuscular effect (4) Difference in effect-site concentration for between the concentration of rocuronium effective site for electromyography-based and acceleromyography-based neuromuscular monitoring